Global Molecular Transport Medium Market

Molecular Transport Medium Comprehensive Study by Type (Viral Transport Medium, Virus Swabs), Indication (Mumps Virus, Influenza, Rhinovirus, Adenovirus, COVID-19, Other), End User (Diagnostic Laboratories, Microbiology Laboratories, Hospitals & Clinics, Others) Players and Region - Global Market Outlook to 2030

Molecular Transport Medium Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Molecular Transport Medium
The demand for molecular transport medium is being driven by an increase in the number of experiments conducted in laboratories and research institutes, increased awareness of laboratory coworker health, rapid antigen testing, and molecular assay experiments, an increase in the number of diagnostic market players, and an increase in the number of infectious diseases such as influenza. Because it inactivates the virus or pathogen, Molecular Transport Medium (MTM) is the safest alternative for transportation, whereas samples held in traditional transport mediums, such as viral transport medium or universal transport medium, will remain infectious and pose safety issues.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR4.5%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Molecular Transport Medium market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific (United States), BD (United States), Medical Wire & Equipment (United Kingdom), COPAN Diagnostics Inc. (United States), Titan Biotech Ltd (India), EKF Diagnostics (United Kingdom), Trinity Biotech (Ireland) and Puritan Medical Products (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Molecular Transport Medium market by Type (Viral Transport Medium and Virus Swabs) and Region.



On the basis of geography, the market of Molecular Transport Medium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Indication, the sub-segment i.e. Mumps Virus will boost the Molecular Transport Medium market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Diagnostic Laboratories will boost the Molecular Transport Medium market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising expenditure by the government to develop healthcare processes and technologies

Market Growth Drivers:
Rising awareness for the health of co-workers in the laboratory and Surge in the number of infectious diseases like influenza

Challenges:
Streight Government Regulation

Opportunities:
Increasing number of experiments at labs and research institutes and Rising number of players in the diagnostic market

Market Leaders and their expansionary development strategies
In October 2023, Longhorn Vaccines and Diagnostics announced new data from the USDA National Veterinary Services Laboratory validating the company’s core diagnostic product, PrimeStore Molecular Transport Medium (PS-MTM), and its potential to inactivate highly consequential livestock and poultry viruses to support safer and more effective diagnostic testing. The results of this study may be utilized by diagnostic testing laboratories for highly pathogenic agents affecting animal and human populations to revise guidance for select agent diagnostic testing and shipment of infectious substances. The data were published in a recent preprint publication of bioRxiv.
In July 2020, EKF Diagnostics, a global in vitro diagnostics company, has announced that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range. PrimeStore® MTM (Molecular Transport Medium) is an FDA cleared and CE IVD marked sample collection device which deactivates viruses, including COVID-19, flu A, flu B, HIV and TB. Already proven in the U.S. market, this fully patented device ensures transportation and workplace safety for disease testing programs, greatly reducing risk of infection to health workers, couriers, and lab technicians.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Molecular Transport Medium Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, End-Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Viral Transport Medium
  • Virus Swabs
By Indication
  • Mumps Virus
  • Influenza
  • Rhinovirus
  • Adenovirus
  • COVID-19
  • Other

By End User
  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising awareness for the health of co-workers in the laboratory
      • 3.2.2. Surge in the number of infectious diseases like influenza
    • 3.3. Market Challenges
      • 3.3.1. Streight Government Regulation
    • 3.4. Market Trends
      • 3.4.1. Rising expenditure by the government to develop healthcare processes and technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Transport Medium, by Type, Indication, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Molecular Transport Medium (Value)
      • 5.2.1. Global Molecular Transport Medium by: Type (Value)
        • 5.2.1.1. Viral Transport Medium
        • 5.2.1.2. Virus Swabs
      • 5.2.2. Global Molecular Transport Medium by: Indication (Value)
        • 5.2.2.1. Mumps Virus
        • 5.2.2.2. Influenza
        • 5.2.2.3. Rhinovirus
        • 5.2.2.4. Adenovirus
        • 5.2.2.5. COVID-19
        • 5.2.2.6. Other
      • 5.2.3. Global Molecular Transport Medium by: End User (Value)
        • 5.2.3.1. Diagnostic Laboratories
        • 5.2.3.2. Microbiology Laboratories
        • 5.2.3.3. Hospitals & Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Molecular Transport Medium Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Molecular Transport Medium: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BD (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medical Wire & Equipment (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. COPAN Diagnostics Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Titan Biotech Ltd (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. EKF Diagnostics (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Trinity Biotech (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Puritan Medical Products (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Molecular Transport Medium Sale, by Type, Indication, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Molecular Transport Medium (Value)
      • 7.2.1. Global Molecular Transport Medium by: Type (Value)
        • 7.2.1.1. Viral Transport Medium
        • 7.2.1.2. Virus Swabs
      • 7.2.2. Global Molecular Transport Medium by: Indication (Value)
        • 7.2.2.1. Mumps Virus
        • 7.2.2.2. Influenza
        • 7.2.2.3. Rhinovirus
        • 7.2.2.4. Adenovirus
        • 7.2.2.5. COVID-19
        • 7.2.2.6. Other
      • 7.2.3. Global Molecular Transport Medium by: End User (Value)
        • 7.2.3.1. Diagnostic Laboratories
        • 7.2.3.2. Microbiology Laboratories
        • 7.2.3.3. Hospitals & Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Molecular Transport Medium Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Transport Medium: by Type(USD Million)
  • Table 2. Molecular Transport Medium Viral Transport Medium , by Region USD Million (2018-2023)
  • Table 3. Molecular Transport Medium Virus Swabs , by Region USD Million (2018-2023)
  • Table 4. Molecular Transport Medium: by Indication(USD Million)
  • Table 5. Molecular Transport Medium Mumps Virus , by Region USD Million (2018-2023)
  • Table 6. Molecular Transport Medium Influenza , by Region USD Million (2018-2023)
  • Table 7. Molecular Transport Medium Rhinovirus , by Region USD Million (2018-2023)
  • Table 8. Molecular Transport Medium Adenovirus , by Region USD Million (2018-2023)
  • Table 9. Molecular Transport Medium COVID-19 , by Region USD Million (2018-2023)
  • Table 10. Molecular Transport Medium Other , by Region USD Million (2018-2023)
  • Table 11. Molecular Transport Medium: by End User(USD Million)
  • Table 12. Molecular Transport Medium Diagnostic Laboratories , by Region USD Million (2018-2023)
  • Table 13. Molecular Transport Medium Microbiology Laboratories , by Region USD Million (2018-2023)
  • Table 14. Molecular Transport Medium Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 15. Molecular Transport Medium Others , by Region USD Million (2018-2023)
  • Table 16. South America Molecular Transport Medium, by Country USD Million (2018-2023)
  • Table 17. South America Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 18. South America Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 19. South America Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 20. Brazil Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 21. Brazil Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 22. Brazil Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 23. Argentina Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 24. Argentina Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 25. Argentina Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 26. Rest of South America Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 27. Rest of South America Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 28. Rest of South America Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 29. Asia Pacific Molecular Transport Medium, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 32. Asia Pacific Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 33. China Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 34. China Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 35. China Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 36. Japan Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 37. Japan Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 38. Japan Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 39. India Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 40. India Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 41. India Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 42. South Korea Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 43. South Korea Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 44. South Korea Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 45. Taiwan Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 46. Taiwan Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 47. Taiwan Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 48. Australia Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 49. Australia Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 50. Australia Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 54. Europe Molecular Transport Medium, by Country USD Million (2018-2023)
  • Table 55. Europe Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 56. Europe Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 57. Europe Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 58. Germany Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 59. Germany Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 60. Germany Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 61. France Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 62. France Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 63. France Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 64. Italy Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 65. Italy Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 66. Italy Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 67. United Kingdom Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 68. United Kingdom Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 69. United Kingdom Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 70. Netherlands Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 71. Netherlands Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 72. Netherlands Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 73. Rest of Europe Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 74. Rest of Europe Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 75. Rest of Europe Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 76. MEA Molecular Transport Medium, by Country USD Million (2018-2023)
  • Table 77. MEA Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 78. MEA Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 79. MEA Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 80. Middle East Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 81. Middle East Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 82. Middle East Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 83. Africa Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 84. Africa Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 85. Africa Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 86. North America Molecular Transport Medium, by Country USD Million (2018-2023)
  • Table 87. North America Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 88. North America Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 89. North America Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 90. United States Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 91. United States Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 92. United States Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 93. Canada Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 94. Canada Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 95. Canada Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 96. Mexico Molecular Transport Medium, by Type USD Million (2018-2023)
  • Table 97. Mexico Molecular Transport Medium, by Indication USD Million (2018-2023)
  • Table 98. Mexico Molecular Transport Medium, by End User USD Million (2018-2023)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Molecular Transport Medium: by Type(USD Million)
  • Table 108. Molecular Transport Medium Viral Transport Medium , by Region USD Million (2025-2030)
  • Table 109. Molecular Transport Medium Virus Swabs , by Region USD Million (2025-2030)
  • Table 110. Molecular Transport Medium: by Indication(USD Million)
  • Table 111. Molecular Transport Medium Mumps Virus , by Region USD Million (2025-2030)
  • Table 112. Molecular Transport Medium Influenza , by Region USD Million (2025-2030)
  • Table 113. Molecular Transport Medium Rhinovirus , by Region USD Million (2025-2030)
  • Table 114. Molecular Transport Medium Adenovirus , by Region USD Million (2025-2030)
  • Table 115. Molecular Transport Medium COVID-19 , by Region USD Million (2025-2030)
  • Table 116. Molecular Transport Medium Other , by Region USD Million (2025-2030)
  • Table 117. Molecular Transport Medium: by End User(USD Million)
  • Table 118. Molecular Transport Medium Diagnostic Laboratories , by Region USD Million (2025-2030)
  • Table 119. Molecular Transport Medium Microbiology Laboratories , by Region USD Million (2025-2030)
  • Table 120. Molecular Transport Medium Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 121. Molecular Transport Medium Others , by Region USD Million (2025-2030)
  • Table 122. South America Molecular Transport Medium, by Country USD Million (2025-2030)
  • Table 123. South America Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 124. South America Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 125. South America Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 126. Brazil Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 127. Brazil Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 128. Brazil Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 129. Argentina Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 130. Argentina Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 131. Argentina Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 132. Rest of South America Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 133. Rest of South America Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 134. Rest of South America Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 135. Asia Pacific Molecular Transport Medium, by Country USD Million (2025-2030)
  • Table 136. Asia Pacific Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 137. Asia Pacific Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 138. Asia Pacific Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 139. China Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 140. China Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 141. China Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 142. Japan Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 143. Japan Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 144. Japan Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 145. India Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 146. India Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 147. India Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 148. South Korea Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 149. South Korea Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 150. South Korea Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 151. Taiwan Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 152. Taiwan Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 153. Taiwan Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 154. Australia Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 155. Australia Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 156. Australia Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 160. Europe Molecular Transport Medium, by Country USD Million (2025-2030)
  • Table 161. Europe Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 162. Europe Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 163. Europe Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 164. Germany Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 165. Germany Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 166. Germany Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 167. France Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 168. France Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 169. France Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 170. Italy Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 171. Italy Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 172. Italy Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 173. United Kingdom Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 174. United Kingdom Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 175. United Kingdom Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 176. Netherlands Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 177. Netherlands Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 178. Netherlands Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 179. Rest of Europe Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 180. Rest of Europe Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 181. Rest of Europe Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 182. MEA Molecular Transport Medium, by Country USD Million (2025-2030)
  • Table 183. MEA Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 184. MEA Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 185. MEA Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 186. Middle East Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 187. Middle East Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 188. Middle East Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 189. Africa Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 190. Africa Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 191. Africa Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 192. North America Molecular Transport Medium, by Country USD Million (2025-2030)
  • Table 193. North America Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 194. North America Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 195. North America Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 196. United States Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 197. United States Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 198. United States Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 199. Canada Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 200. Canada Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 201. Canada Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 202. Mexico Molecular Transport Medium, by Type USD Million (2025-2030)
  • Table 203. Mexico Molecular Transport Medium, by Indication USD Million (2025-2030)
  • Table 204. Mexico Molecular Transport Medium, by End User USD Million (2025-2030)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Transport Medium: by Type USD Million (2018-2023)
  • Figure 5. Global Molecular Transport Medium: by Indication USD Million (2018-2023)
  • Figure 6. Global Molecular Transport Medium: by End User USD Million (2018-2023)
  • Figure 7. South America Molecular Transport Medium Share (%), by Country
  • Figure 8. Asia Pacific Molecular Transport Medium Share (%), by Country
  • Figure 9. Europe Molecular Transport Medium Share (%), by Country
  • Figure 10. MEA Molecular Transport Medium Share (%), by Country
  • Figure 11. North America Molecular Transport Medium Share (%), by Country
  • Figure 12. Global Molecular Transport Medium share by Players 2023 (%)
  • Figure 13. Global Molecular Transport Medium share by Players (Top 3) 2023(%)
  • Figure 14. Global Molecular Transport Medium share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 18. BD (United States) Revenue, Net Income and Gross profit
  • Figure 19. BD (United States) Revenue: by Geography 2023
  • Figure 20. Medical Wire & Equipment (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. Medical Wire & Equipment (United Kingdom) Revenue: by Geography 2023
  • Figure 22. COPAN Diagnostics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. COPAN Diagnostics Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Titan Biotech Ltd (India) Revenue, Net Income and Gross profit
  • Figure 25. Titan Biotech Ltd (India) Revenue: by Geography 2023
  • Figure 26. EKF Diagnostics (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. EKF Diagnostics (United Kingdom) Revenue: by Geography 2023
  • Figure 28. Trinity Biotech (Ireland) Revenue, Net Income and Gross profit
  • Figure 29. Trinity Biotech (Ireland) Revenue: by Geography 2023
  • Figure 30. Puritan Medical Products (United States) Revenue, Net Income and Gross profit
  • Figure 31. Puritan Medical Products (United States) Revenue: by Geography 2023
  • Figure 32. Global Molecular Transport Medium: by Type USD Million (2025-2030)
  • Figure 33. Global Molecular Transport Medium: by Indication USD Million (2025-2030)
  • Figure 34. Global Molecular Transport Medium: by End User USD Million (2025-2030)
  • Figure 35. South America Molecular Transport Medium Share (%), by Country
  • Figure 36. Asia Pacific Molecular Transport Medium Share (%), by Country
  • Figure 37. Europe Molecular Transport Medium Share (%), by Country
  • Figure 38. MEA Molecular Transport Medium Share (%), by Country
  • Figure 39. North America Molecular Transport Medium Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • BD (United States)
  • Medical Wire & Equipment (United Kingdom)
  • COPAN Diagnostics Inc. (United States)
  • Titan Biotech Ltd (India)
  • EKF Diagnostics (United Kingdom)
  • Trinity Biotech (Ireland)
  • Puritan Medical Products (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 153 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Molecular Transport Medium Market Quantitative research analysis
Global Molecular Transport Medium Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific (United States), BD (United States), Medical Wire & Equipment (United Kingdom), COPAN Diagnostics Inc. (United States), Titan Biotech Ltd (India), EKF Diagnostics (United Kingdom), Trinity Biotech (Ireland) and Puritan Medical Products (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising expenditure by the government to develop healthcare processes and technologies" is seen as one of major influencing trends for Molecular Transport Medium Market during projected period 2023-2030.
The Molecular Transport Medium market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Molecular Transport Medium Market Report?

Have a Query? Click Here

Other Related Reports

Home Care - Comprehensive Study by Indication (Cardiovascular Disorders & Hypertension, Respiratory Diseases, Diabetes, Cancer, Wound Care, Pregnancy, Mobility Disorders, Other), Connectivity (CRM, T...
$ 3750
Chikungunya Rapid Testing Comprehensive Study by Technique (Serological testing techniques, Molecular testing techniques), End User (Hospitals, Academic Institutes, Diagnostic Centres, Research Insti...
$ 3350
Homeopathic Injectable Comprehensive Study by Sales Channels (Online Sales Channel, Offline Sales Channels), Types of administration (Subcutaneous Administration, Intraarticular Administration, Peri...
$ 3350
Guided Bone Regeneration Comprehensive Study by Type (Ceramic-based, Polymer-based, Growth factor-based, Cell-based, Others), Application (Orthopedic Surgery, Bone Trauma, Dental Surgery, Others), En...
$ 3650
Electronic Prescription Service Comprehensive Study by Type (Integrated Solutions, Standalone Solutions), Deployment Mode (Cloud-Based, On-Premise), End- User (Hospitals, Office-based Physicians, Pha...
$ 3450
Pets Telehealth - Comprehensive Study by Application (Household, Veterinary Clinics), Platform (IOS, Android), Pricing (Monthly Subscription, Annual Subscription), Features (Virtual consultations, Te...
$ 3450